Archives

by in
Entry Author Date Location
West Coast Biotech Roundup: Amgen Layoffs, Avalanche, Venter & More 07/31/14 Seattle
Hutch Starts Search for New Prez as Corey Steps Down 05/08/14 Seattle
BioPharma Learns From Marvel, Begins Real Life Search For “X-Men” 04/30/14 Seattle
Gilead Following Multiple Paths Toward HIV “Functional Cure” 03/24/14 San Francisco
East Coast Biotech Roundup: ImmusanT, NY Disruptors, Tesaro, & More 03/14/14 Boston
HIV Treatment Outlook Buoyed by Sangamo Gene Therapy 03/10/14 San Francisco
Seattle BioMed Nabs $10M NIAID Grant to Develop HIV Vaccines 03/10/14 Seattle
ZappRx Gets $1M From Atlas, SR One to E-Prescribe Specialty Meds 01/30/14 Boston
Enanta, No Longer Obscure, Seeks Slice of Big Hepatitis C Market 01/24/14 Boston
How Nelson Mandela Inspired Me to Fight Infectious Disease 12/16/13 Seattle
Gates Foundation Health Chief on Coaxing Pharma to Do Good 11/25/13 National
Biotech and Fantasy Football Picks for Fall 2013 09/03/13 National
Sangamo in Race to Replace Chronic Drug Treatment with Gene Therapies 07/15/13 San Francisco
Gilead Sciences Building on HIV, Becoming Cancer Drug Force 04/01/13 National
Drug Development: Let’s Play! 03/21/13 Seattle
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
Bridesmaid No More: It is Time For Diagnostics To Shine 07/02/12 National
AIDS Drugs Were the Start. Let’s See More FDA Accelerated Approvals 03/12/12 National
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting 01/23/12 National
Merck Leads $10M Funding of HIV Diagnostics Firm Daktari 01/03/12 Boston
The Hepatitis C Market: Biotech’s Version of the Daytona 500 12/12/11 National
Theraclone Names Cliff Stocks, Vet of Icos & Calistoga, as New CEO 12/06/11 Seattle
Sangamo Fails Diabetic Neuropathy Study, Falls Back on HIV, Other Programs 10/03/11 San Francisco
Gates Foundation Adds Novartis Vet, Trevor Mundel, as New Global Health Leader 09/13/11 Seattle
Theraclone Snaps Up $10.6M Financing 09/08/11 Seattle
(Mis)Understanding Drug Discovery: It’s Much Harder Than Rocket Science 09/07/11 Seattle
Theraclone Nabs Industry Award, Scopes Out Extra $10M Financing 09/06/11 Seattle
Dramatic Changes in Hepatitis C Treatment Expected to Continue 09/06/11 San Diego
Seattle Genetics’ Market Debut, Pathway Gets Bought, Theraclone’s Latest Trick Against HIV, & More Seattle-Area Life Sciences News 08/25/11 Seattle
Consortium Find New HIV Antibodies, Zogenix Gets Drug to Clinical End Point, TrovaGene Reclaims Technology, & More San Diego Life Sciences News 08/18/11 San Diego
Page 1 of 6 next page »